Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias
The Impact of Mindful Walking on Neural Correlates of Executive Function in SC Older Adults at Risk of Alzheimer's and Dementias
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Phase
Phase
- Phase 2
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Halle Prine, MS
- Numéro de téléphone: 8039997392
- E-mail: HPRINE@email.sc.edu
Lieux d'étude
-
-
South Carolina
-
Columbia, South Carolina, États-Unis, 29201
- Recrutement
- University of South Carolina
-
Contact:
- Chih-Hsiang Yang
- Numéro de téléphone: 8037771025
- E-mail: cy11@mailbox.sc.edu
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 60 or older
- Sedentary (sit ≥9hrs per day) and not meeting the US physical activity guidelines
Have at least one of the following ADRD risk factors:
i. family history of ADRD (>= first-degree relative) ii. subjective experience of cognitive complaints iii. currently overweight or obese (BMI≥25)
- Adequate hearing, visual and cognitive ability to complete study tasks and assessments
- Able to walk without others' assistance
- Medically stable with or without medication (do not expect to have major health status changes or a surgery in the next 4 months)
Exclusion Criteria:
- Diagnosis of ADRD or other brain abnormalities (i.e., strokes, epilepsy, Parkinson's disease)
- Diagnosis of mental disorders (i.e., depression)
- Inability to complete surveys on mobile device or wear the activity monitor (i.e., due to arthritis, physical limitations, or other reasons)
- Plan to move or have surgery in next 4 months
- Currently participate in other study involving physical activity or cognitive training that may interfere with the study outcomes
- Unable to provide consent due to disabilities
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Mindful walking arm
Older adults will participate in 8 sessions of mindful walking over one month
|
Implementing mindfulness skills during the walking movement
|
|
Comparateur actif: Walking-only arm
Older adults will participate in 8 sessions of walking over one month
|
Older adults will participate in 8 sessions of walking over one month without being trained on mindfulness skills.
|
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Hemodynamic activation signal
Délai: Assessed at baseline, 4 weeks, 8 weeks
|
Hemodynamic activation in the prefrontal and parietal regions as an indication of EF.
Neural activation will be measured using functional nearinfrared spectroscopy (fNIRS).
|
Assessed at baseline, 4 weeks, 8 weeks
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Neuropsychological function
Délai: Assessed at baseline, 4 weeks, 8 weeks
|
Montreal Cognitive Assessment (MoCA) is sensitive to measure normal cognitive aging from those with mild cognitive decline.
MoCA scores range from 1-30 to detect cognitive impairment.
Higher scores indicate better cognitive function.
|
Assessed at baseline, 4 weeks, 8 weeks
|
|
Executive function
Délai: Assessed at Baseline, 4 weeks, 8 weeks
|
NIH Toolbox Cognitive Battery will be used to measure fluid cognitive abilities
|
Assessed at Baseline, 4 weeks, 8 weeks
|
|
Trait Mindfulness Levels
Délai: Assessed at Baseline, 4 weeks, 8 weeks
|
Using the validated five-facet mindfulness scale (FFMQ) to measure trait mindfulness.
FFMQ scores range from 39-195.
Higher scores indicate higher trait mindfulness levels.
|
Assessed at Baseline, 4 weeks, 8 weeks
|
|
State Mindfulness Levels
Délai: Assessed at baseline, 4 weeks, 8 weeks
|
Using the validated state mindfulness scale (SMS) to measure state mindfulness.
SMS scores range from 21-105.
Higher scores indicate higher state mindfulness levels.
|
Assessed at baseline, 4 weeks, 8 weeks
|
Autres mesures de résultats
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Overall (in)activity levels
Délai: Assessed at Baseline, 8 weeks
|
Using the physical activity and sedentary behavior questionnaire (PASB-Q) to assess older adults' overall (in)activity levels.
The questionnaire asks participants about their typical weekly physical activity minutes and daily sitting hours.
|
Assessed at Baseline, 8 weeks
|
|
Overall everyday cognition
Délai: Assessed at Baseline, 8 weeks
|
Using everyday cognition scale (ECog) to assess memory, planning, organization, and divided attention in daily contexts.
Each item ranges from 1-4 points.
The overall score is calculated as an average of all completed items, resulting in a score range of 1 to 4. The higher scores represent worse everyday cognition.
|
Assessed at Baseline, 8 weeks
|
|
Overall health status
Délai: Assessed at Baseline, 8 weeks
|
Using SF-36 questionnaire to assess overall health status.
For all domain scales and component scores, the scoring range is 0 to 100, with higher scores representing a more favorable or higher level of health.
|
Assessed at Baseline, 8 weeks
|
|
Height
Délai: Assessed at Baseline, 8 weeks
|
Applying the NIH PhenX Toolkit protocol.
Participants' standing height is measured from the top of the participant's head to their heels.
The measure will be conducted in duplicates and will be recorded to the nearest 0.1 cm.
This measure will be combined with the weight measure to measure participants' BMI in kg/ m^2.
|
Assessed at Baseline, 8 weeks
|
|
Weight
Délai: Baseline, 8 weeks
|
Applying the NIH PhenX Toolkit protocol.
Participants' weight will be measured using a digital floor scale.
Their weight will be measured in duplicates and will be recorded to the nearest 0.1 kg.
This measure will be combined with the height measure to calculate participants' BMI in kg/ m^2.
|
Baseline, 8 weeks
|
|
Mobility
Délai: Assessed at baseline, 8 weeks
|
Applying the NIH PhenX Toolkit 10-meter walk protocol to assess mobility.
The test outcome is typically expressed as gait speed in meters per second (m/s).
The lower values indicate a higher risk of adverse health events.
|
Assessed at baseline, 8 weeks
|
|
Demographics
Délai: Assessed at baseline
|
Collected basic demographics via an online survey.
All items are assessed using multiple-choice or multiple-selection questions of different types of participants' demographic status.
The response options are thus categorical but not a scale.
|
Assessed at baseline
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Collaborateurs
Collaborateurs
Publications et liens utiles
Publications générales
- Yang CH, Maher JP, Conroy DE. Acceptability of mobile health interventions to reduce inactivity-related health risk in central Pennsylvania adults. Prev Med Rep. 2015 Aug 13;2:669-72. doi: 10.1016/j.pmedr.2015.08.009. eCollection 2015.
- Carpenter C, Yang CH, West D. A Comparison of Sedentary Behavior as Measured by the Fitbit and ActivPAL in College Students. Int J Environ Res Public Health. 2021 Apr 8;18(8):3914. doi: 10.3390/ijerph18083914.
- Yang CH, Huh J, Mason TB, Belcher BR, Kanning M, Dunton GF. Mother-child dyadic influences of affect on everyday movement behaviors: evidence from an ecological momentary assessment study. Int J Behav Nutr Phys Act. 2020 May 11;17(1):56. doi: 10.1186/s12966-020-00951-6.
- Lopez NV, Yang CH, Belcher BR, Margolin G, Dunton GF. Within-Subject Associations of Maternal Physical Activity Parenting Practices on Children's Objectively Measured Moderate-to-Vigorous Physical Activity. J Pediatr Psychol. 2019 Apr 1;44(3):300-310. doi: 10.1093/jpepsy/jsy100.
- Yang CH, Hakun JG, Roque N, Sliwinski MJ, Conroy DE. Mindful walking and cognition in older adults: A proof of concept study using in-lab and ambulatory cognitive measures. Prev Med Rep. 2021 Jul 14;23:101490. doi: 10.1016/j.pmedr.2021.101490. eCollection 2021 Sep.
- Yang CH, Conroy DE. Feasibility of an Outdoor Mindful Walking Program for Reducing Negative Affect in Older Adults. J Aging Phys Act. 2018 Nov 7:1-10. doi: 10.1123/japa.2017-0390. Online ahead of print.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- MODCR00000007
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .